Summary
Definition
History and exam
Key diagnostic factors
- calf swelling
- localized pain along deep venous system
Other diagnostic factors
- asymmetric edema
- prominent superficial veins
- swelling of the entire leg
- phlegmasia cerulea dolens
Risk factors
- major surgery within the preceding 3 months
- medical hospitalization within the preceding 2 months
- active cancer
- previous venous thromboembolic event
- recent trauma or fracture
- increasing age
- pregnancy and the postpartum
- paralysis of the lower extremities
- factor V Leiden
- prothrombin gene G20210A mutation
- protein C or protein S deficiency
- antithrombin deficiency
- antiphospholipid syndrome
- medical comorbidity
- use of specific drugs
- obesity
- cigarette smoking
- recent long-distance air travel
- family history
- central venous catheterization
Diagnostic tests
1st tests to order
- Wells score
- quantitative D-dimer level
- proximal duplex ultrasound
- whole-leg ultrasound
- INR and activated partial thromboplastin time (aPTT)
- BUN and creatinine
- LFTs
- CBC
Tests to consider
- Doppler venous flow testing
- CT abdomen and pelvis with contrast
- thrombophilia screen
Treatment algorithm
initiation-phase therapy: no active bleeding
initiation-phase therapy: active bleeding
treatment-phase therapy
extended-phase therapy (3 months’ anticoagulation therapy completed): not postpartum, no recurrence
extended-phase therapy: postpartum (planning to breastfeed)
extended-phase therapy: postpartum (not planning to breastfeed)
extended-phase therapy: recurrent VTE
Contributors
Authors
Scott M. Stevens, MD
Director
Thrombosis Clinic
Intermountain Medical Center
Murray
Professor of Medicine
Department of Medicine
Intermountain Healthcare and University of Utah
Salt Lake City
UT
Disclosures
SMS serves as co-chair of the American College of Chest Physicians guideline on the treatment of venous thrombotic disease. He is the author of several references cited in this topic.
Scott C. Woller, MD
Director
Thrombosis Clinic
Intermountain Medical Center
Murray
Professor of Medicine
Department of Medicine
Intermountain Healthcare and University of Utah
Salt Lake City
UT
Disclosures
SCW serves as co-chair of the American College of Chest Physicians guideline on the treatment of venous thrombotic disease. He is the author of several references cited in this topic.
Gabriel V. Fontaine, PharmD, MBA, BCPS
Clinical Pharmacy Manager
Critical Care and Emergency Medicine
Advanced Clinical Pharmacist
Neuroscience Critical Care
Intermountain Medical Center
Murray
UT
Disclosures
GVF has received consulting fees and honoraria from Alexion Pharmaceuticals.
Acknowledgements
Dr Scott M. Stevens, Dr Scott C. Woller, and Dr Gabriel V. Fontaine would like to gratefully acknowledge Dr Geno Merli, Dr Taki Galanis, Dr Luis Eraso, Dr Geoffrey Ouma, Dr Richard White, and Dr Windsor Ting, the previous contributors to this topic.
Disclosures
GM has received grant or research support from BMS, J&J, Sanofi-Aventis, Portola, and Janssen; he has served as a Scientific Consultant for BMS, J&J, and Sanofi-Aventis. RW declares participation in numerous multicentered clinical trials sponsored by companies: Agenix, Boehringer-Ingleheim, Amgen, Bayer, Bristol-Meyer-Squibb, Novartis, Hemosense. TG, LE, GO, and WT declare that they have no competing interests.
Peer reviewers
Beverly Hunt, FRCP, FRCPath, MD
Professor of Thrombosis & Haemostasis
King's College
Consultant
Departments of Haematology, Pathology & Rheumatology
Lead in Blood Sciences
Guy's & St Thomas' NHS Foundation Trust
London
UK
Disclosures
BH declares that she has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
References
Key articles
Stevens SM, Woller SC, Baumann Kreuziger L, et al. Executive summary: antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report. Chest. 2021 Dec;160(6):2247-59.Full text Abstract
Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 suppl):e195S-226S.Full text Abstract
Mazzolai L, Aboyans V, Ageno W, et al. Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral circulation and pulmonary circulation and right ventricular function. Eur Heart J. 2018 Dec 14;39(47):4208-18. [Erratum in: Eur Heart J. 2018 Apr 14;39(15):1316.]Full text Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Differentials
- Cellulitis
- Calf muscle tear/Achilles tendon tear
- Calf muscle hematoma
More DifferentialsGuidelines
- Venous thromboembolic diseases: diagnosis, management and thrombophilia testing
- Venous thromboembolism prophylaxis and treatment in patients with cancer
More GuidelinesPatient information
Deep vein thrombosis
DVT and long-distance travel
More Patient informationCalculators
Modified Wells score for deep vein thrombosis (DVT)
Pretest Probability of Heparin Induced Thrombocytopenia (4-T's score)
More CalculatorsLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer